Hijji Fady Y, Cheslik Thomas G, Schneider Andrew D, Schach Blake M, Venkatarayappa Indresh
Department of Orthopaedic Surgery, Boonshoft School of Medicine, Wright State University, Dayton, OH, USA.
Shoulder Elbow. 2021 Jun;13(3):237-247. doi: 10.1177/1758573220935865. Epub 2020 Jun 29.
Patient-reported outcomes (PROs) are frequently utilized within orthopaedics to determine the extent of patient disease and the efficacy of surgical treatments. Shoulder arthroplasty is a common treatment option for a range of pathologies; however, substantial variety exists regarding the instruments used within the published literature, limiting their quality and generalizability. The purpose of the present systematic review is to evaluate the overall number and frequency of outcome measures used in all clinical studies evaluating outcomes following shoulder arthroplasty.
This systematic review was performed following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Relevant studies that assessed patient reported outcomes following total shoulder arthroplasty, reverse shoulder arthroplasty, and shoulder hemiarthroplasty were obtained from PubMed, MEDLINE, and EMBASE databases. For each manuscript, the journal, authors, region of origin, level of evidence, and subject/pathology were recorded. The frequency of each reported outcome measure and category. Associations between study characteristics and measure categories were tested using Poisson regression with robust error variance.
A total of 682 articles were included in the analysis, reporting 42 different PROs. The most popular tools were the Constant-Murley score (49.7%), the American Shoulder and Elbow Surgeons Evaluation Form (37.7%), and the Visual Analog Scale (34.3%). A generic outcome tool was used in 287 studies (42.1%), while 645 (94.6%) utilized a shoulder-specific measure and 49 (7.2%) used a disease-specific measure. The use of generic (p<0.001) and disease specific (p<0.001) measures were associated with higher level of evidence.
Studies assessing patient outcomes following shoulder arthroplasty employ a large range of PRO measuring tools, many of which are non-validated. Furthermore, only a small percentage of studies utilize a combination of tools from different categories despite current recommendations. Consensus on validated and clinically-meaningful tools from multiple categories is necessary to increase the generalizability and applicability of published studies in shoulder arthroplasty literature.
患者报告结局(PROs)在骨科领域经常被用于确定患者疾病的程度以及手术治疗的疗效。肩关节置换术是治疗多种病症的常见选择;然而,已发表文献中使用的器械存在很大差异,这限制了研究的质量和可推广性。本系统评价的目的是评估所有评估肩关节置换术后结局的临床研究中所使用结局指标的总数和频率。
本系统评价按照系统评价和Meta分析的首选报告项目(PRISMA)指南进行。从PubMed、MEDLINE和EMBASE数据库中获取评估全肩关节置换术、反肩关节置换术和肩关节半置换术后患者报告结局的相关研究。对于每篇手稿,记录期刊、作者、来源地区、证据水平以及主题/病理情况。记录每个报告结局指标和类别的频率。使用具有稳健误差方差的泊松回归检验研究特征与指标类别之间的关联。
共有682篇文章纳入分析,报告了42种不同的PROs。最常用的工具是Constant-Murley评分(49.7%)、美国肩肘外科医生评估表(37.7%)和视觉模拟量表(34.3%)。287项研究(42.1%)使用了通用结局工具,而645项研究(94.6%)使用了肩关节特异性指标,49项研究(7.2%)使用了疾病特异性指标。使用通用指标(p<0.001)和疾病特异性指标(p<0.001)与更高的证据水平相关。
评估肩关节置换术后患者结局的研究采用了大量的PRO测量工具,其中许多未经验证。此外,尽管有当前的建议,但只有一小部分研究使用了来自不同类别的工具组合。需要就来自多个类别的经过验证且具有临床意义的工具达成共识,以提高已发表研究在肩关节置换术文献中的可推广性和适用性。
1级